Loading...
OTCM
RHHBY
Market cap270bUSD
Mar 31, Last price  
41.15USD
1D
-1.84%
1Q
17.98%
Jan 2017
44.23%
Name

Roche Holding AG

Chart & Performance

D1W1MN
No data to show
P/E
3.62
P/S
0.48
EPS
10.05
Div Yield, %
3.81%
Shrs. gr., 5y
-1.43%
Rev. gr., 5y
-0.43%
Revenues
62.40b
+3.23%
35,511,000,00042,041,000,00046,133,000,00045,617,000,00049,051,000,00047,473,000,00042,531,000,00045,499,000,00048,612,000,00049,866,000,00050,403,000,00052,636,000,00055,746,000,00059,497,000,00063,751,000,00058,323,000,00062,801,000,00063,281,000,00060,441,000,00062,395,000,000
Net income
8.28b
-28.01%
6,730,000,0007,880,000,0009,761,000,0008,969,000,0007,784,000,0008,666,000,0009,343,000,0009,539,000,00011,164,000,0009,332,000,0008,863,000,0009,576,000,0008,633,000,00010,500,000,00013,497,000,00014,295,000,00013,930,000,00012,421,000,00011,498,000,0008,277,000,000
CFO
20.09b
+24.85%
9,975,000,00010,329,000,00011,728,000,00012,177,000,00016,877,000,00014,342,000,00012,954,000,00015,005,000,00015,772,000,00015,930,000,00015,251,000,00015,001,000,00018,024,000,00019,979,000,00022,385,000,00018,160,000,00020,569,000,00017,890,000,00016,095,000,00020,094,000,000
Dividend
Mar 14, 20241.56832 USD/sh
Earnings
Jul 24, 2025

Profile

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.
URL
https://www.roche.com/
IPO date
May 04, 2001
Employees
103,613
Domiciled in
CH
Incorporated in
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
62,395,000
3.23%
60,441,000
-4.49%
63,281,000
0.76%
Cost of revenue
46,483,000
45,438,000
56,727,000
Unusual Expense (Income)
NOPBT
15,912,000
15,003,000
6,554,000
NOPBT Margin
25.50%
24.82%
10.36%
Operating Taxes
2,606,000
1,721,000
2,796,000
Tax Rate
16.38%
11.47%
42.66%
NOPAT
13,306,000
13,282,000
3,758,000
Net income
8,277,000
-28.01%
11,498,000
-7.43%
12,421,000
-10.83%
Dividends
(7,650,000)
(7,590,000)
(7,446,000)
Dividend yield
3.72%
3.86%
3.20%
Proceeds from repurchase of equity
(1,130,000)
(1,144,000)
(2,514,000)
BB yield
0.55%
0.58%
1.08%
Debt
Debt current
4,257,000
4,691,000
4,262,000
Long-term debt
33,797,000
27,664,000
22,282,000
Deferred revenue
160,000
227,000
254,000
Other long-term liabilities
5,528,000
5,470,000
6,607,000
Net debt
30,221,000
20,942,000
15,680,000
Cash flow
Cash from operating activities
20,094,000
16,095,000
17,890,000
CAPEX
(3,529,000)
(3,742,000)
(4,552,000)
Cash from investing activities
(11,393,000)
(10,643,000)
(3,568,000)
Cash from financing activities
(6,819,000)
(4,239,000)
(15,718,000)
FCF
14,150,000
10,563,000
2,890,000
Balance
Cash
17,317,000
10,510,000
9,767,000
Long term investments
(9,484,000)
903,000
1,097,000
Excess cash
4,713,250
8,390,950
7,699,950
Stockholders' equity
48,343,000
46,402,000
32,015,000
Invested Capital
73,489,750
61,351,050
53,642,050
ROIC
19.74%
23.10%
6.94%
ROCE
20.13%
21.33%
10.57%
EV
Common stock shares outstanding
804,000
804,000
800,000
Price
255.50
4.50%
244.50
-15.83%
290.50
-23.37%
Market cap
205,422,000
4.50%
196,578,000
-15.41%
232,400,000
-28.72%
EV
240,037,000
234,607,000
252,103,000
EBITDA
19,335,000
18,477,000
10,378,000
EV/EBITDA
12.41
12.70
24.29
Interest
1,403,000
997,000
608,000
Interest/NOPBT
8.82%
6.65%
9.28%